✦ LIBER ✦

PCN132 Duration of Gefitinib Treatment in EGFR Mutation Positive NSCLC Patients in a UK Single Payement Access Scheme (SPA)

✍ Scribed by H. Vioix; S. Franzen; D. Selby; O. Hauch; C.E. Emmas

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Three Years of the Gefitinib UK Single P

✍ Vioix, H.; Franzen, S.; Selby, D.; Collomb, D.; Hauch, O.; Emmas, C. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

68O EFFICACY, SAFETY AND TOLERABILITY RE

✍ Douillard, J.; Ostoros, G.; Cobo, M.; Ciuleanu, T.; McCormack, R.; Webster, A.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 45 KB